These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1683640)

  • 1. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic prolyl hydroxylase activity in human liver disease.
    McPhie JL
    Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.
    Carter EA; McCarron MJ; Alpert E; Isselbacher KJ
    Gastroenterology; 1982 Mar; 82(3):526-34. PubMed ID: 6119272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolyl hydroxylase activity in liver specimens in chronic liver diseases (author's transl)].
    Langness U; Clausnitzer H; Verspohl M; Grasedyck K
    Med Klin; 1978 Aug; 73(34):1179-82. PubMed ID: 210365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
    Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
    Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum cathepsin activity in chronic liver diseases].
    Kucharz EJ; Kucharz M
    Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
    Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
    Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum collagenase activity in chronic liver diseases.
    Murawaki Y; Kawasaki H; Burkhardt H
    Pathol Res Pract; 1994 Oct; 190(9-10):929-33. PubMed ID: 7899142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase activity in liver and serum of rats and human subjects intoxicated by chronic administration of ethanol.
    Pawlicka E; Bańkowski E; Pałka J; Markiewicz W
    Hepatogastroenterology; 1987 Dec; 34(6):243-5. PubMed ID: 2828207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma collagen-binding vitronectin activated by heparin and dextran sulfate in chronic liver disease.
    Yamada S; Kobayashi J; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):315-24. PubMed ID: 9387191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
    Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
    Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
    Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lysyl oxidase activity in patients with various liver diseases.
    Sakamoto M; Murawaki Y; Hirayama C
    Gastroenterol Jpn; 1987 Dec; 22(6):730-6. PubMed ID: 2895030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics.
    Ventura P; Rosa MC; Abbati G; Marchini S; Grandone E; Vergura P; Tremosini S; Zeneroli ML
    Liver Int; 2005 Feb; 25(1):49-56. PubMed ID: 15698398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
    Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
    Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.